Vemurafenib in the Treatment of Brain Metastases From Melanoma

Onkologiya. Zhurnal imeni P.A.Gertsena
doi 10.17116/oncolog2014685-89
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Media Sphere Publishing Group

Related search

Determinants of Survival in Patients With Brain Metastases From Cutaneous Melanoma

British Journal of Cancer
Cancer ResearchOncology
2010English

Brain Distribution and Active Efflux of Three panRAF Inhibitors: Considerations in the Treatment of Melanoma Brain Metastases

Journal of Pharmacology and Experimental Therapeutics
Molecular MedicinePharmacology
2019English

Surgical Treatment of Pulmonary Metastases From Melanoma: Emerging Options

2011English

Whole Brain Radiotherapy (WBRT) After Local Treatment of Brain Metastases in Melanoma Patients: Statistical Analysis Plan

Trials
MedicinePharmacology
2019English

Clinical Management of Multiple Melanoma Brain Metastases

JAMA Oncology
Cancer ResearchOncology
2015English

Molecular Insights Into Melanoma Brain Metastases

Cancer
Cancer ResearchOncology
2017English

Challenges in the Delivery of Therapies to Melanoma Brain Metastases

Current Pharmacology Reports
BiochemistryDrug DiscoveryGeneticsPharmacology
2016English

Treatment of Brain Metastases

Revista da Associacao Medica Brasileira
Medicine
2016English

Simultaneous Treatment of Severe Vemurafenib-Induced Uveitis and Metastatic Melanoma

Journal of Clinical & Experimental Ophthalmology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy